- Home
- SMFG vs BMY Comparison
SMFG vs BMY Comparison
Compare SMFG & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMFG
- BMY
- Stock Information
- Founded
- SMFG 2002
- BMY 1887
- Country
- SMFG Japan
- BMY United States
- Employees
- SMFG N/A
- BMY N/A
- Industry
- SMFG Commercial Banks
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- SMFG Finance
- BMY Health Care
- Exchange
- SMFG Nasdaq
- BMY Nasdaq
- Market Cap
- SMFG 96.4B
- BMY 99.7B
- IPO Year
- SMFG 1949
- BMY N/A
- Fundamental
- Price
- SMFG $16.84
- BMY $48.04
- Analyst Decision
- SMFG
- BMY Hold
- Analyst Count
- SMFG 0
- BMY 15
- Target Price
- SMFG N/A
- BMY $57.64
- AVG Volume (30 Days)
- SMFG 2.0M
- BMY 12.7M
- Earning Date
- SMFG 07-31-2025
- BMY 07-31-2025
- Dividend Yield
- SMFG 2.36%
- BMY 5.12%
- EPS Growth
- SMFG N/A
- BMY N/A
- EPS
- SMFG 0.86
- BMY 2.49
- Revenue
- SMFG $23,194,711,070.00
- BMY $47,704,000,000.00
- Revenue This Year
- SMFG $39.22
- BMY N/A
- Revenue Next Year
- SMFG $3.98
- BMY N/A
- P/E Ratio
- SMFG $31.62
- BMY $19.47
- Revenue Growth
- SMFG N/A
- BMY 2.57
- 52 Week Low
- SMFG $11.83
- BMY $42.96
- 52 Week High
- SMFG $17.46
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- SMFG 62.38
- BMY 60.36
- Support Level
- SMFG $16.52
- BMY $48.07
- Resistance Level
- SMFG $17.46
- BMY $49.58
- Average True Range (ATR)
- SMFG 0.17
- BMY 0.90
- MACD
- SMFG 0.06
- BMY 0.32
- Stochastic Oscillator
- SMFG 67.37
- BMY 84.81
About SMFG Sumitomo Mitsui Financial Group Inc Unsponsored (Japan)
Sumitomo Mitsui Financial Group is roughly tied with Mizuho Financial Group for the status of Japan's second-largest bank after Mitsubishi UFJ Financial Group. As of March 2024, its market share of domestic loans was 7.2%, compared with 8.0% for MUFG. It has a larger consumer finance business than the other two megabanks, owning 100% of the Promise business and SMBC Card. It also controls one of Japan's largest leasing companies and SMBC Aviation Capital, one of the top five aircraft lessors globally. In securities, its SMBC Nikko unit is Japan's third-largest retail broker, although SMFG has lagged somewhat in institutional securities business and asset management.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.